首页 | 本学科首页   官方微博 | 高级检索  
     

柳氮磺胺吡啶和氢化泼尼松对大鼠结肠炎模型调节性T细胞的影响
引用本文:尤鹏,刘玉兰,刘安楠. 柳氮磺胺吡啶和氢化泼尼松对大鼠结肠炎模型调节性T细胞的影响[J]. 免疫学杂志, 2006, 22(1): 72-75
作者姓名:尤鹏  刘玉兰  刘安楠
作者单位:1. 北京大学人民医院消化科,北京,100044
2. 北京医院特需医疗科,北京,100034
摘    要:目的 探讨CD4^+ CD25^+和CD8^+ CD28^-调节性T细胞在2,4,6-三硝基苯磺酸(TNBS)诱发的大鼠实验性结肠炎模型的外周血、脾脏、结肠的改变及其作用。方法 建立TNBS实验性结肠炎大鼠模型。设对照组、建模后1周及3周组、柳氮磺胺吡啶(SASP)和氢化泼尼松(PSL)治疗组(在建模1周后分别每日给予SASP及PSL灌胃,治疗2周)共5组,用流式细胞仪检测各组外周血、脾脏和结肠黏膜上皮细胞内单个核细胞中CD4^+ CD25^+和CD8^+ CD28^-调节性T细胞比例的变化;肠道积分评定组织学变化。结果 成功建立了TNBS大鼠模型。CD4^+ CD25^+ T细胞:建模后第1周在外周血、脾、结肠均较对照组升高,至第3周已恢复至对照组水平,SASP治疗后无变化,PSL治疗后在外周血、脾、结肠均明显低于建模后3周组。CD8^+ CD28^- T细胞:建模第1周在外周血、脾、结肠均较对照组升高,至第3周仍高于对照组水平,SASP治疗后在脾、结肠中较建模后3周组下降。PSL治疗后在外周血、脾、结肠均明显低于建模后3周组。结论 CD4^+ CD25^+和CD8^+ CD28^-这两种调节性T细胞可能在实验性结肠炎发病的不同阶段中起着一定作用,且以局部作用为主。CD8^+ CD28^- T细胞可能与慢性炎症变化成正相关。PSL、SASP对大鼠实验性结肠炎均有明显疗效,PSL可减少CD8^+ CD28^- T细胞量,较SASP疗效更显著。

关 键 词:2,4,6-三硝基苯磺酸  实验性结肠炎  调节性T细胞  柳氮磺胺吡啶  氢化泼尼松
文章编号:1000-8861(2006)01-0072-04
收稿时间:2004-10-26
修稿时间:2005-01-05

Changes of T regulatory cells in rats with experimental colitis after drug treatment with SASP and PSL
YOU Peng,LIU Yu-lan,LIU An-nan. Changes of T regulatory cells in rats with experimental colitis after drug treatment with SASP and PSL[J]. Immunological Journal, 2006, 22(1): 72-75
Authors:YOU Peng  LIU Yu-lan  LIU An-nan
Abstract:Objective To explore the changes of CD4~+CD25~+ and CD8~+CD28~-T regulatory cells in rats with experimental colitis induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS) after drug treatment with salicylazosulfapyridine(SASP) and prednisolone(PSL).Methods The model of experimental colitis was established through TNBS enema.Thirty-nine adult SD rats were randomly divided into 5 groups: normal control group,experimental colitis model groups(1 week and 3 weeks),SASP therapeutic group,and PSL therapeutic group.The proportion of CD4~+CD25~+ and CD8~+CD28~-T regulatory cells in peri-(pheral) blood,spleen mononuclear cells,and intraepithelial lymphocytes of rat colons were determined by flow cytometry.Results The rat model of TNBS-induced colitis was established successfully.The CD4~+CD25~+ Tr in peripheral blood,spleen mononuclear cells,and intraepithelial lymphocytes of colon from experimental colitis model group(1 week) were higher than those from normal control group.The level of CD4~+CD25~+ Tr in experimental colitis model group was decreased to that of normal control group after 3 weeks,and did not change after SASP treatment.The level of CD4~+CD25~+ Tr of PSL-therapeutic group was significantly lower than that of experimental colitis model group.The CD8~+CD28~-Tr in peripheral blood,spleen mononuclear cells,and intraepithelial lymphocytes of colon were higher in experimental colitis model group than in normal control group from 1 week to 3 weeks.The CD8~+CD28~-Tr of SASP therapeutic group was lower than that of experimental colitis model group in spleen mononuclear cells and intraepithelial lymphocytes of colon.The CD8~+CD28~-Tr of PSL therapeutic group was significantly lower than that of experimental colitis model group in peripheral blood,spleen mononuclear cells,and intraepithelial lymphocytes of colon. Conclusion CD4~+CD25~+ and CD8~+CD28~T regulatory cells may be have relations with the different phases of colitis.CD8~+CD28~-T cells are positively correlated with chronic inflammation;SASP and PSL have decreased the proportion of CD8~+CD28~-T regulatory cells,and have therapeutic effects on experimental colitis,especially PSL.
Keywords:TNBS   Experimental colitis   T regulatory cells   SASP   PSL
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号